EICHOR
● Withdrawn
Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment
Condition: Helicobacter Pylori Infection · Sponsor: Shanghai Zhongshan Hospital
About this study
This multicenter randomized controlled clinical trial was conducted to compare the eradication efficacy and health economic benefits of individualized regimens based on HP drug resistance mutation gene detection (multiple PCR method), individualized regimens based on HP traditional drug sensitivity testing (E-test method) and empirical regimens in the Helicobacter pylori treatment.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (3)
| Renji Hospital, School of Medicine, Shanghai Jiaotong University | Shanghai, Shanghai Municipality, China | — |
| Zhongshan Hospital, Fudan University | Shanghai, Shanghai Municipality, China | — |
| Huashan Hospital, Fudan University | Shanghai, Shanghai Municipality, China | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05250050